FDA Approves OXYMORPHONE HYDROCHLORIDE — Epic Pharma, LLC
Epic Pharma, LLC received FDA approval for its Abbreviated New Drug Application covering oral Oxymorphone Hydrochloride tablets, positioning the company to intensify competition in the opioid pain management market and drive generic price erosion.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day